3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
32
Neoplasm Metastasis
4
Metastatic Castration-Resistant Prostate Cancer
2
Newly Diagnosed Oligometastatic Prostate Cancer
1
Neoplasms
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Metastatic Castration Resistant Prostate Cancer
1
Castration-resistant Prostate Cancer
1
Castrate Sensitive Prostate Cancer
1
Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy
1
Advanced Prostate Carcinoma
1
Interventions
abiraterone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy
×
abiraterone
×
Clear all
NCT01780220
2022-05-19
CARLHA
UNICANCER
Phase 1/2
Completed
47 enrolled